Cargando…
The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis
BACKGROUND: Tuberculosis (TB) is still the single pathogen infectious disease with the largest number of deaths worldwide. The relationship that intestinal microbiota disorder and de novo fatty acid synthesis metabolism have with disease progression in multi-drug resistant TB (MDR-TB) has not yet be...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509681/ https://www.ncbi.nlm.nih.gov/pubmed/36168638 http://dx.doi.org/10.2147/IDR.S372122 |
_version_ | 1784797281586774016 |
---|---|
author | Shi, Jichan Gao, Gexin Yu, Zhijie Wu, Kaihuai Huang, Youquan Wu, Lian-Peng Wu, Zhengxing Ye, Xinchun Qiu, Chaochao Jiang, Xiangao |
author_facet | Shi, Jichan Gao, Gexin Yu, Zhijie Wu, Kaihuai Huang, Youquan Wu, Lian-Peng Wu, Zhengxing Ye, Xinchun Qiu, Chaochao Jiang, Xiangao |
author_sort | Shi, Jichan |
collection | PubMed |
description | BACKGROUND: Tuberculosis (TB) is still the single pathogen infectious disease with the largest number of deaths worldwide. The relationship that intestinal microbiota disorder and de novo fatty acid synthesis metabolism have with disease progression in multi-drug resistant TB (MDR-TB) has not yet been fully studied. OBJECTIVE: To investigate the effects of long periods of MDR-TB, pre-extensively drug-resistant TB (pre-XDR-TB), or rifampicin-resistant TB (RR-TB) on gut microbiome dysbiosis and advanced disease. METHODS: The sample was chosen between March 2019 and September 2019 in Wenzhou Central Hospital and comprised 11 patients with pre-XDR-TB, 23 patients with RR-TB, and 28 patients with MDR-TB. Healthy individuals were chosen as the control group (CK group). An overnight fast blood sample was drawn via venipuncture into tubes without anticoagulant. For analysis, 300 mg of faeces from patients from the same group was mixed and analysed using DNA extraction, NGS sequencing, and bioinformatics. A QIAamp Fecal DNA Mini Kit was used to isolate the DNA. The extracted DNA was stored at −20°C. RESULTS: Advanced TB was concurrent with an elevated level of the proportions of acetyl-CoA carboxylase (ACC1) to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and fatty acid synthase (FASN) to GAPDH in de novo fatty acids synthesis, and Eubacterium, Faecalibacterium, Roseburia, and Ruminococcus were increased significantly in RR-TB patients compared to healthy individuals, whereas their abundance in the pre-XDR-TB and MDR-TB groups showed little change in comparison with the control group. Proteobacteria levels were greatly increased in the RR-TB and MDR-TB patient groups but not in the patients with pre-XDR-TB or the healthy subjects. The pre-XDR-TB group exhibited alterations of the intestinal microbiome: coliform flora showed the highest abundance of Verrucomicrobiales, Enterobacteriales, Bifidobacteriales and Lactobacillales. De novo fatty acids synthesis was enhanced in patients and was associated with the gut microbiome dysbiosis induced by the antimicrobials, with Bacteroidetes, Bacteroidales, and Bacteroidaceae displaying the most important correlations on a phylum, order, and family level, respectively. CONCLUSION: The progression to advanced TB was observed to be a result of the interaction between multiple interrelated pathways, with gut–lung crosstalk potentially playing a role in patients with drug-resistant TB. |
format | Online Article Text |
id | pubmed-9509681 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-95096812022-09-26 The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis Shi, Jichan Gao, Gexin Yu, Zhijie Wu, Kaihuai Huang, Youquan Wu, Lian-Peng Wu, Zhengxing Ye, Xinchun Qiu, Chaochao Jiang, Xiangao Infect Drug Resist Original Research BACKGROUND: Tuberculosis (TB) is still the single pathogen infectious disease with the largest number of deaths worldwide. The relationship that intestinal microbiota disorder and de novo fatty acid synthesis metabolism have with disease progression in multi-drug resistant TB (MDR-TB) has not yet been fully studied. OBJECTIVE: To investigate the effects of long periods of MDR-TB, pre-extensively drug-resistant TB (pre-XDR-TB), or rifampicin-resistant TB (RR-TB) on gut microbiome dysbiosis and advanced disease. METHODS: The sample was chosen between March 2019 and September 2019 in Wenzhou Central Hospital and comprised 11 patients with pre-XDR-TB, 23 patients with RR-TB, and 28 patients with MDR-TB. Healthy individuals were chosen as the control group (CK group). An overnight fast blood sample was drawn via venipuncture into tubes without anticoagulant. For analysis, 300 mg of faeces from patients from the same group was mixed and analysed using DNA extraction, NGS sequencing, and bioinformatics. A QIAamp Fecal DNA Mini Kit was used to isolate the DNA. The extracted DNA was stored at −20°C. RESULTS: Advanced TB was concurrent with an elevated level of the proportions of acetyl-CoA carboxylase (ACC1) to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and fatty acid synthase (FASN) to GAPDH in de novo fatty acids synthesis, and Eubacterium, Faecalibacterium, Roseburia, and Ruminococcus were increased significantly in RR-TB patients compared to healthy individuals, whereas their abundance in the pre-XDR-TB and MDR-TB groups showed little change in comparison with the control group. Proteobacteria levels were greatly increased in the RR-TB and MDR-TB patient groups but not in the patients with pre-XDR-TB or the healthy subjects. The pre-XDR-TB group exhibited alterations of the intestinal microbiome: coliform flora showed the highest abundance of Verrucomicrobiales, Enterobacteriales, Bifidobacteriales and Lactobacillales. De novo fatty acids synthesis was enhanced in patients and was associated with the gut microbiome dysbiosis induced by the antimicrobials, with Bacteroidetes, Bacteroidales, and Bacteroidaceae displaying the most important correlations on a phylum, order, and family level, respectively. CONCLUSION: The progression to advanced TB was observed to be a result of the interaction between multiple interrelated pathways, with gut–lung crosstalk potentially playing a role in patients with drug-resistant TB. Dove 2022-09-21 /pmc/articles/PMC9509681/ /pubmed/36168638 http://dx.doi.org/10.2147/IDR.S372122 Text en © 2022 Shi et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Shi, Jichan Gao, Gexin Yu, Zhijie Wu, Kaihuai Huang, Youquan Wu, Lian-Peng Wu, Zhengxing Ye, Xinchun Qiu, Chaochao Jiang, Xiangao The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis |
title | The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis |
title_full | The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis |
title_fullStr | The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis |
title_full_unstemmed | The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis |
title_short | The Relevance of Host Gut Microbiome Signature Alterations on de novo Fatty Acids Synthesis in Patients with Multi-Drug Resistant Tuberculosis |
title_sort | relevance of host gut microbiome signature alterations on de novo fatty acids synthesis in patients with multi-drug resistant tuberculosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509681/ https://www.ncbi.nlm.nih.gov/pubmed/36168638 http://dx.doi.org/10.2147/IDR.S372122 |
work_keys_str_mv | AT shijichan therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT gaogexin therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT yuzhijie therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT wukaihuai therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT huangyouquan therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT wulianpeng therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT wuzhengxing therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT yexinchun therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT qiuchaochao therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT jiangxiangao therelevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT shijichan relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT gaogexin relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT yuzhijie relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT wukaihuai relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT huangyouquan relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT wulianpeng relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT wuzhengxing relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT yexinchun relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT qiuchaochao relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis AT jiangxiangao relevanceofhostgutmicrobiomesignaturealterationsondenovofattyacidssynthesisinpatientswithmultidrugresistanttuberculosis |